Xem mẫu

TOMAN’S TUBERCULOSIS CASE DETECTION, TREATMENT, AND MONITORING The second edition of this practical, authoritative reference book provides a rational basis for the diagnosis and management of tuberculosis. Written by a number of experts in the field, it remains faithful to Kurt Toman’s original question-and-answer format, with subject matter grouped under the three headings Case detection, Treatment, and Monitoring. It is a testament to the enduring nature of the first edition that so much material has been retained unchanged. At the same time, the new edition has had not only to address the huge resurgence of tuber-culosis, the emergence of multidrug-resistant bacilli, and the special needs of HIV-infected individuals with tuberculosis, but also to encompass significant scientific advances. These changes in the profile of the disease and in approaches to management have inevitably prompted many new questions and answers and given a different complexion to others. Toman’s Tuberculosis remains essential reading for all who need to learn more about every aspect of tuberculosis – case-finding, manage-ment, and effective control strategies. It provides invaluable support to anyone in the front line of the battle against this disease, from programme managers to policy-makers and from medical personnel to volunteer health workers. QUESTIONS AND ANSWERS SECOND EDITION ISBN 92 4 154603 4 WORLD HEALTH ORGANIZATION WHO GENEVA Toman’s Tuberculosis Case detection, treatment, and monitoring – questions and answers SECOND EDITION Edited by T. Frieden WORLD HEALTH ORGANIZATION GENEVA 2004 WHO Library Cataloguing-in-Publication Data Toman’s tuberculosis case detection, treatment, and monitoring : questions and answers / edited by T. Frieden. – 2nd ed. 1.Tuberculosis, Pulmonary – diagnosis 2.Tuberculosis, Pulmonary – drug therapy 3.Tuberculosis, Multidrug-resistant 4.Antitubercular agents – pharmacology I.Toman, Kurt. II.Frieden, Thomas R. III.Title: Tuberculosis case detection, treatment, and monitoring. ISBN 92 4 154603 4 (NLM classification: WF 360) WHO/HTM/TB/2004.334 © World Health Organization 2004 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expres-sion of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.Errors and omissions excepted,the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. The editor and authors alone are responsible for the views expressed in this publication. Further information is available at: CDS Information Resource Centre, World Health Organization, 1211 Geneva 27, Switzerland; fax: (+41) 22 791 4285, e-mail: cdsdocs@who.int Designed by minimum graphics Typeset in Hong Kong Printed in China Contents Preface to the First Edition viii Preface to the Second Edition ix Introduction xi Acknowledgements for the First Edition xiii Acknowledgements for the Second Edition xiv Contributors xvi Case detection 1. What is the role of case detection in tuberculosis control?1 F. Luelmo 3 2. What is a case of tuberculosis?1 F. Luelmo 5 3. What is the role of sputum microscopy in patients attending health facilities? F. Luelmo 7 4. How many bacilli are present in a sputum specimen found positive by smear microscopy? K. Toman 11 5. How reliable is smear microscopy? K. Toman 14 6. What are the main causes of false-positive and false-negative sputum smears? K. Toman 23 7. What are the main consequences of false-positive and false-negative sputum smears? T. Frieden 28 8. What are the advantages and disadvantages of fluorescence microscopy? K. Toman 31 9. What is the role of mycobacterial culture in diagnosis and case definition?1 A. Van Deun 35 10. What is the probability of obtaining a negative culture from a sputum specimen found positive by smear microscopy? K. Toman 44 1 Based on the chapter in the previous edition by K. Toman. iii TOMAN’S TUBERCULOSIS 11. What is the additional yield from repeated sputum examinations by smear microscopy and culture?1 A. Harries 46 12. How reliable is chest radiography?1 R. Koppaka & N. Bock 51 13. What are the relative merits of chest radiography and sputum examination (smear microscopy and culture) in case detection among new outpatients with prolonged chest symptoms?1 A. Harries 61 14. How does pulmonary tuberculosis develop and how can it be detected at an early stage? K. Toman 66 15. What is the role of case detection by periodic mass radiographic examination in tuberculosis control?1 H. Rieder 72 16. How does the diagnosis of tuberculosis in persons infected with HIV differ from diagnosis in persons not infected with HIV? A. Harries 80 17. What is the role of tuberculin skin testing in the diagnosis of tuberculosis? D. Menzies 84 18. What is the current and potential role of diagnostic tests other than sputum microscopy and culture? D. Menzies 87 19. How can public and private sectors cooperate to detect, treat, and monitor tuberculosis cases? T. Frieden 92 Treatment 20. What were the main landmarks in the development of tuberculosis treatment? K. Toman 99 21. How does tuberculosis treatment work? K. Toman 102 22. What is the role of host factors in the pathogenesis, prevention, and treatment of tuberculosis? M. Iademarco & M. Reichler 106 23. What is the therapeutic effect and what is the toxicity of autituberculosis drugs?1 T. Frieden & M. Espinal 110 24. What is the purpose of the initial intensive phase of two-phase treatment? K. Toman 122 25. What are the current recommendations for standard regimens? A. Harries 124 26. What are the diagnostic categories and what is the rationale for these categories? A. Harries 128 27. What is intermittent treatment and what is the scientific basis for intermittency?1 T. Frieden 130 1 Based on the chapter in the previous edition by K. Toman. iv ... - tailieumienphi.vn
nguon tai.lieu . vn